This inventor holds 4 USPTO granted patents, plus 1 CIPO patent. Top assignees: Adimab, LLC, Merck Sharp + Dohme Corp.. Active years: 2018-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Palo Alto, CA (US) (2018 - 2020)
- San Jose, CA (US) (2023)
Company Filing History:
4 out of 52 
4 out of 2,405 
Years Active: 2018-2025
Title: Vaishnavi Ganti: Innovator in Anti-Coagulation Research
Introduction
Vaishnavi Ganti is a prominent inventor based in Palo Alto, CA, known for her significant contributions to the field of anti-coagulation research. With a total of 4 patents, she has made remarkable strides in developing innovative solutions that address critical health issues related to blood coagulation.
Latest Patents
Among her latest patents, Ganti has developed anti-coagulation factor XI antibodies. These antibodies bind to the apple 3 domain of human coagulation Factor XI, inhibiting its activation by coagulation factor XIIa. Additionally, they prevent the activation of FIX by FXIa, showcasing her commitment to advancing medical science and improving patient outcomes.
Career Highlights
Throughout her career, Vaishnavi Ganti has worked with esteemed organizations such as Merck Sharp & Dohme Corporation and Adimab, LLC. Her experience in these companies has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Ganti has had the opportunity to work alongside notable colleagues, including Zhu Chen and Kenneth Ellsworth. These collaborations have further enriched her research and innovation efforts.
Conclusion
Vaishnavi Ganti's work in anti-coagulation research exemplifies her dedication to innovation and improving healthcare solutions. Her patents and collaborations highlight her impact in the field, making her a noteworthy inventor in today's scientific landscape.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile